Načítá se...
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™
Aplidin™ (APL) is a new antitumoral drug from marine origin currently in phase II clinical trials against a wide multiplicity of cancers. As resistance may be, as with other drugs, an important obstacle to the APL therapeutic efficacy, we have established an acquired resistance cellular model by con...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Nature Publishing Group
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2409906/ https://ncbi.nlm.nih.gov/pubmed/15365569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602166 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|